331 ETH
Pill imprint 331 ETH has been identified as Propafenone hydrochloride 150 mg.
Propafenone is used in the treatment of atrial fibrillation; ventricular tachycardia; wolff-parkinson-white syndrome; atrial flutter and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy.
Propafenone 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Propafenone hydrochloride Images
- Imprint:
-
331
ETH - Strength:
- 150 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Group I antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Ethex Corporation
- National Drug Code (NDC):
- 58177-0331
| NDC Code | Manufacturer / Repackager |
|---|---|
| 58016-0303 | Southwood Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Propafenone Hydrochloride resources
- Propafenone (Wolters Kluwer)
- Propafenone Sustained-Release Capsules (Wolters Kluwer)
- propafenone (Cerner Multum)
- propafenone (Micromedex) - Includes Dosage Information
- Propafenone Hydrochloride (AHFS DI)
- Propafenone (FDA)
- Propafenone Extended Release Capsule (FDA)
- Propafenone (Wolters Kluwer)
Search Again
